Review: Malaria chemoprophylaxis for travelers to Latin America.

Authors:
Address: Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Prevention and Control, Atlanta, Georgia 30333, USA. LSteinhardt@cdc.gov
Journal:


Publication:

abstract

Because of recent declining Malaria transmission in Latin America, some authorities have recommended against chemoprophylaxis for most travelers to this region. However, the predominant parasite species in Latin America, Plasmodium vivax, can form hypnozoites sequestered in the liver, causing malaria relapses. Additionally, new evidence shows the potential severity of vivax infections, warranting continued consideration of prophylaxis for travel to Latin America. Individualized travel risk assessments are recommended and should consider travel locations, type, length, and season, as well as probability of itinerary changes. Travel recommendations might include no precautions, mosquito avoidance only, or mosquito avoidance and chemoprophylaxis. There are a range of good options for chemoprophylaxis in Latin America, including atovaquone-proguanil, doxycycline, mefloquine, and--in selected areas--chloroquine. Primaquine should be strongly considered for nonpregnant, G6PD-nondeficient patients traveling to vivax-endemic areas of Latin America, and it has the added benefit of being the only drug to protect against malaria relapses.



Related Articles
The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
J Travel Med. 2003
The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
Kofoed K, Petersen E. J Travel Med. 2003 May-Jun; 10(3):150-4.
Prophylactic use of antimalarials during pregnancy.
Can Fam Physician. 2011
Prophylactic use of antimalarials during pregnancy.
Irvine MH, Einarson A, Bozzo P. Can Fam Physician. 2011 Nov; 57(11):1279-81.
Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.
J Travel Med. 2006
Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.
Jiménez BC, Navarro M, Huerga H, López-Román E, Mendoza A, López-Vélez R. J Travel Med. 2006 Nov-Dec; 13(6):373-5.
Review Controversies and misconceptions in malaria chemoprophylaxis for travelers.
JAMA. 2007
Review Controversies and misconceptions in malaria chemoprophylaxis for travelers.
Chen LH, Wilson ME, Schlagenhauf P. JAMA. 2007 May 23; 297(20):2251-63.
Review Malaria prevention in travelers.
Am Fam Physician. 1999
Review Malaria prevention in travelers.
Juckett G. Am Fam Physician. 1999 May 1; 59(9):2523-30, 2535-6.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.